Search

Search Results

• 

  Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

  Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

  314-322

  15-12-2015

  https://doi.org/10.4081/itjm.2015.468

  2031

  PDF: 976

  HTML: 1261

• Acute severe renal failure in a patient receiving apixaban: a case report

  Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

  09-04-2024

  https://doi.org/10.4081/itjm.2024.1718

  908

  PDF: 500

  HTML: 76

• Assessment and predictors of inappropriate dose of direct oral anticoagulants

  Mosaad O. Almegren

  09-01-2024

  https://doi.org/10.4081/itjm.2024.1679

  1100

  pdf: 558

  HTML: 146
• 

  Apixaban

  Gianluca Airoldi, Mauro Campanini

  128-134

  07-03-2013

  https://doi.org/10.4081/itjm.2011.128

  1260

  PDF: 1980
• 

  Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

  Andrea Rubboli

  22-28

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.22

  1068

  PDF: 812
• 

  Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

  Luca Masotti, Mauro Campanini

  1-7

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.1

  12217

  PDF: 3108
• 

  Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  153-169

  23-10-2012

  https://doi.org/10.4081/itjm.2012.153

  1747

  PDF: 2099

• The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

  Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

  17-02-2025

  https://doi.org/10.4081/itjm.2025.1807

  2173

  PDF: 468

  HTML: 1
• 

  New oral anticoagulants: key messages for clinicians

  Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

  74-84

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.74

  1341

  PDF: 964
• 

  The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

  Luca Masotti, Giancarlo Landini, Grazia Panigada

  48-58

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.48

  1453

  PDF: 1036
• 

  New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

  Mauro Silingardi

  65-70

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.65

  1404

  PDF: 993
• 

  Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  8-21

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.8

  1391

  PDF: 972
• 

  Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

  Giancarlo Landini, Luca Masotti

  41-47

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.41

  973

  PDF: 879

• Patent foramen ovale and stroke: a possible association with deep vein thrombosis

  Raffaele Natale, Luca Maria Capece, Sofia Donnarumma, Pasquale Madonna, Carolina Bologna, Domenico Birra, Antonietta De Sena, Marina Lugarà, Claudio De Luca, Mariavittoria Guerra, Gabriella Oliva, Fabio Granato Corigliano, Paolo Tirelli, Vincenzo Nuzzo

  29-10-2024

  https://doi.org/10.4081/itjm.2024.1801

  1614

  PDF: 695

  HTML: 155
• 

  The treatment of venous thromboembolism with new oral anticoagulants

  Davide Imberti

  29-35

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.29

  1128

  PDF: 914
• 

  Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

  Andrea Fontanella, Pierpaolo Di Micco

  59-64

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.59

  989

  PDF: 960
• 

  Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct

  Marco Masina

  171-174

  30-09-2016

  https://doi.org/10.4081/itjm.2016.720

  1476

  PDF: 980

  HTML: 636

• Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

  Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

  25-11-2024

  https://doi.org/10.4081/itjm.2024.1846

  1260

  PDF: 452

  SUPPLEMENTARY MATERIAL: 279

  ACKNOWLEDGMENTS: 245

  HTML: 139
• 

  A dangerous adverse event in the use of dabigatran

  Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

  250-251

  09-11-2015

  https://doi.org/10.4081/itjm.2015.629

  1662

  PDF: 988

  HTML: 260
• 

  Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

  Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

  202-206

  30-09-2016

  https://doi.org/10.4081/itjm.2016.690

  1740

  PDF: 956

  HTML: 805

• Utility of the aspirin and P2Y12 response assays to determine the effects of antiplatelet agents in patients with subdural hematoma undergoing neurosurgery

  Ombretta Para, Christian Carleo, Francesco Bucci, Lucia Lipari, Asim Raza, Edoardo Cesaroni, Chiara La Rovere, Simone Orlandini, Gastone Pansini, Alberto Parenti, Giovanni Muscas, Alessandro Della Puppa

  14-07-2025

  https://doi.org/10.4081/itjm.2025.1926

  602

  PDF: 584

  HTML: 0
• 

  Cryptogenic stroke

  Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

  185-194

  30-09-2016

  https://doi.org/10.4081/itjm.2016.682

  2007

  PDF: 1225

  HTML: 603
• 

  How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

  Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

  20-11-2023

  https://doi.org/10.4081/itjm.2023.1656

  1147

  PDF: 452

  HTML: 30

• P110 | Use of DOACs in the treatment of deep vein thrombosis secondary to inferior vena cava agenesis: A case study from the Provincial Health Services Company of Trento N. Osti¹, V. Racanelli², A. Maino³ | ¹UO di Medicina Interna, Ospedale Valli del Noce, Azienda Provinciale per i Servizi Sanitari di Trento, ²CISMed, Università degli Studi di Trento, ³UO di Medicina Interna, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari di Trento, Italy

  27-08-2025

  https://doi.org/10.4081/itjm.2025.2305

  108
• 

  Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

  Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

  18-03-2021

  https://doi.org/10.4081/itjm.2021.1351

  1247

  PDF: 609

  HTML: 54
• 

  Optimal duration of anticoagulant therapy in patients with venous thromboembolism

  Gualtiero Palareti

  235-244

  14-09-2018

  https://doi.org/10.4081/itjm.2018.1077

  1611

  PDF: 1858

  HTML: 260
• 

  Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

  Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

  134-140

  12-06-2014

  https://doi.org/10.4081/itjm.2014.450

  1701

  PDF: 1328

  Appendix: 620

  HTML: 624
• 

  Young FADOI and gender medicine: sex gender differences in cardiovascular disease

  Tiziana Ciarambino, Miriam Gino, Paola Gnerre, Elena Barbagelata, Nunzia Barone, Francesca Saladini, Federica Lorenzi, Marta Zanon, Maria Cristina Pasquini, Cecilia Politi

  23-31

  20-03-2018

  https://doi.org/10.4081/itjm.2018.864

  2797

  PDF: 1201

  HTML: 493
• 

  Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

  Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

  125-133

  03-06-2014

  https://doi.org/10.4081/itjm.2014.504

  2204

  PDF: 1434

  Appendix: 1131

  HTML: 762